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ABSTRACT
THE PREVALENCE OF TM7a IN HUMAN SUBGINGIVAL PLAQUE
by Jamsheed Ghadiri
Most bacteria are yet to be cultivated, and some uncultivated bacteria have been
associated with human diseases. TM7, an uncultivated candidate division of bacteria, has
been recently associated with periodontitis, a disease if left untreated causes tooth
degradation and gum decay. A subgroup of TM7, known as TM7a, has been found in
both human samples and activated wastewater. TM7a from these two locations are as
high as 99.7% similar by 16S rRNA gene sequence analysis, leading researchers to
believe both TM7a strains are very similar functionally. TM7a has been extensively
studied in activated wastewater. However, little is known of its prevalence in the human
oral cavity. This research surveyed for the first time the prevalence of TM7a in human
subgingival plaque by using a quantitative PCR assay (qPCR) optimized for this study.
The oral cavities of six healthy individuals were sampled. A total of 34 subgingival
plaque samples were collected from 5 – 6 teeth per patient. It was determined by qPCR
that TM7a was present in five of six (83%) patients and in 22 of 34 (64.7%) samples.
The average abundance of TM7a in the human oral cavity was 3.36x107 ± 2.53x106
cells g-1 and comprised 2.88x10-1 % ± 2.16x10-1% – 1.00x10-3% ± 8.65x10-4% total
bacteria. TM7a was also found to be significantly more abundant in plaques collected
from the facial sites (p < 0.0005), and in posterior sites (p < 0.05). These data suggest
that the prevalence of TM7a is dynamic in the human oral cavity and provides the basis
for a potential large-scale study to quantify TM7a in a population.
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Introduction
The vast majority of the bacterial diversity known today consists of strains that
cannot yet be grown in pure culture under laboratory conditions. Since molecular
techniques were first applied to identify bacteria, the number of known phylum-level
lineages increased from 12 (Woese, 1987) to over 100 (Sogin, 2009), most of which are
known as candidate divisions as its members are yet to be cultivated. An estimated 68%
of the human oral flora is composed of uncultured bacteria (Dewhirst et al. 2010). Some
of these uncultivated bacteria have been associated with human oral disease, promoting
an increased effort to understand their role in this infected site (Brinig et al., 2003;
Lawson et al., 1998).
The candidate division TM7 has been detected in a variety of organisms and
environmental sources including garden soil, fresh and marine water, activated
wastewater (Dinis et al., 2011), canines (Dewhirst et al., 2012), and humans (Brinig et al.,
2003; Dewhirst et al., 2010; Dinis et al. 2011). In humans, TM7 has been associated with
the human oral disease, periodontitis, a disease that if left untreated causes tooth and gum
decay (Brinig et al., 2003).
Recently, a subgroup of TM7 known as TM7a was detected on human skin and in
the oral cavity. Interestingly, in 2011, TM7a was also detected in activated wastewater in
San Jose, CA (Dinis et al., 2011). In that study, it was determined that the similarity
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between human oral TM7a and wastewater TM7a was 99.7% based on 16S rDNA gene
sequence analysis. However, TM7a has not been quantified in the human oral cavity.
In this pilot study, I quantified and determined the prevalence of TM7a in the
human oral cavity. The oral cavities of six healthy individuals were sampled. A total of
34 subgingival plaque samples were collected from 5 – 6 teeth per patient.
Quantification of TM7a was performed using an optimized assay I adapted from Dinis et
al. (2011) to understand the prevalence of TM7a in human subgingival plaque.
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Literature Review

Uncultivated Bacteria
In the late 1970s, Carl Woese used molecular techniques to redefine the tree of
life (Woese, 1987). Relying on conserved genes (e.g., the small subunit of the ribosomal
gene, referred to here either as 16S rDNA or 16S rRNA gene), he discovered a clear
distinction within prokaryotes where the kingdom was split into two domains: Archaea
and Eubacteria. In subsequent years, the 16S rRNA gene became the standard marker to
identify bacteria, due to its conserved nature and ideal length for PCR (Lane, 1991). In
the 1990s, researchers developed universal primers to target the 16S rRNA gene based on
known sequencing data (Lane, 1991). These universal bacterial primers have been
utilized to target bacteria within various samples sites. Since their inception, the number
of known bacterial phyla has been increased from 12 (Woese, 1987) to over 100 (Sogin,
2009). As new bacterial domains were discovered, so were the number of phyla
represented only by uncultured bacteria. These phyla are known as “candidate divisions”
as there are no known cultured representatives and their existence is solely based on 16S
rRNA gene studies (Hugenholtz et al., 1998). Over 99% of bacteria remain uncultivated
(Hugenholtz et al., 1998; Rappé and Giovannoni, 2003). Many of these bacteria thrive in
mixed microbial communities with diverse metabolic byproducts and complex microbial
interactions, which have proven difficult to replicate in culturing media (Lewis et al.,
2010; Schmidt and Konopka, 2009). Furthermore, some uncultivated bacteria have been
associated with human diseases, such as gastroenteritis and periodontitis, pushing the
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effort to cultivate these bacteria in order to understand their role in infected sites and
mixed microbial communities (Brinig et al., 2003; Lawson et al., 1998).

TM7 Bacteria
The candidate division TM7 is one of the most extensively studied uncultivated
divisions yet still contains no cultured representatives. TM7 was first discovered in a
German peat bog by targeting the 16S rRNA gene (Hugenholtz et al., 2001). In that
study, the name TM7 was derived from the nomenclature used to identify sequence
clones. TM7 stood for: Torf, mittlere Schicht, or peat, middle layer, clone number 7,
from which the division took its name. Further studies revealed TM7’s ubiquitous nature
in the environment, having been found in environmental sites including garden soil, fresh
and marine water, and activated wastewater (Hugenholtz et al., 2001; Dinis et al. 2011).
TM7 has also been found in organisms, including marine sponges (Hardoim et al., 2009),
canines (Dewhirst et al., 2012), termites (Hugenholtz et al., 2001), and humans (Brinig et
al., 2003; Dinis et al., 2011). Fluorescent in situ hybridization (FISH) observations have
characterized the morphologies of TM7 which range from cocci, bacilli, and filaments
(Ouverney et al. 2003). The size of cocci shaped TM7 cells average 0.5 μm in diameter,
and 1.0 to 5.0 μm for individual bacilli cells (Hugenholtz et al., 2001). Transmission
electron microscopy of TM7 cells has identified a cellular structure similar in
composition to that of Gram-positive bacteria; consequently, it is thought that TM7 is a
gram-positive bacterium (Albertsen et al. 2013; Hugenholtz et al., 2001).
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TM7 in Human Sites
In humans, TM7 has been discovered in a variety of anatomical locations
including the skin, esophagus, intestine, and the oral cavity (Brinig et al., 2003; Gao et al.,
2007; Kuehbacher et al., 2008; Pei et al., 2004). The most extensively studied location is
within the human oral cavity, of which a subdivision of TM7, known as ‘SBG1’ has been
associated with chronic periodontitis (Brinig et al., 2003). Periodontitis is characterized
by the onset of ovular bone degradation caused by bacteria (Oliver et al., 1991). In a
study by Brinig et al. (2003), SBG1 was found to exist in significantly higher abundances
in periodontal patients than in healthy patients (p < 0.001; Fisher’s exact test).
Furthermore, SBG1 cells were longer in diseased sites than in healthy sites (p = 0.003;
unpaired t test) (Brinig et al., 2003; Ouverney et al. 2003). In another study, TM7 was
found in all 12 patients with periodontitis and only in 4 out of 9 without (Kumar et al.,
2003). Due to TM7’s increased prevalence in periodontal sites, TM7 is now associated
with periodontitis and is it is believed that SBG1 may be necessary for the development
of biofilms in these diseased sites (Brinig et al., 2003; Kumar et al., 2003). Additionally,
TM7 has been associated with cystic fibrosis, inflammatory bowel disease, and vaginosis
(Fredricks et al., 2007; Guss et al., 2010; Kuehbacher et al., 2008).
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TM7 Phylogeny
Over the past decade, efforts to establish the phylogeny of TM7 based on 16S
rDNA sequences have been made. TM7 was first thought to contain three monophyletic
subdivisions (Hugenholtz et al., 2001). However, the most recent phylogenetic
representation of TM7 suggests two monophyletic subdivisions (Dinis et al., 2011). In
the most recent study, Dinis et al. (2011) utilized all 255 representative TM7 sequences
from the Genebank public database to create the most accurate and up-to-date
phylogenetic representation of TM7 yet. Among the 255 TM7 sequences included in the
Dinis et al. phylogenetic tree, 160 were classified as environmental, 53 as humanassociated, and 42 as animal (non-human) associated (Dinis et al., 2011). Humanassociated and animal-associated TM7 sequences predominantly clustered in one
subdivision and environmental TM7 in the second. That suggested TM7 bacteria
associated with human and animal hosts shared an evolutionary history not shared by
most environmental TM7. For a few exceptions, however, some TM7 from the
environment had greater homology to the human-associated TM7 than to other
environmental TM7. One novel finding in that study was a clade of TM7 (called TM7a)
that included sequences retrieved from wastewater and from the human oral cavity and
skin (Dinis et al. 2011). TM7a from these two locations are as high as 99.7% similar
based on 16S rDNA sequence comparisons (Dinis et al., 2011). Such level of percent
similarity insinuates the TM7a found in wastewater and TM7a associated with humans
belong to the same species. However, the prevalence and abundance of TM7a in human
subgingival plaque remains unknown.
6

TM7 Genomic Analysis
Beyond the 16S rRNA single gene approach, genomic sequences can provide a
more in-depth analysis by defining genes that are responsible for various functions within
the bacterium. Most of the metabolic and physiological data responsible for the
functional understanding of many uncultivated bacteria was derived from genomic
sequences. Several studies have acquired partial genomic sequences of TM7, one study
was performed in the human oral cavity (Marcy et al. 2007), the other in soil (Podar et al.
2007). These studies made use of multiple displacement amplification (MDA) to amplify
individual cells isolated by either microfluidic devices (Marcy et al., 2007) or via cell
sorting using flow cytometry (Podar et al., 2007). In the human oral cavity, 1,474 genes
were discovered from oral TM7 clone TM7a (Marcy et al., 2007). In soil, whole genome
amplification recovered 670 genes from TM7 clone GTL-1 (Podar et al., 2007). Gene
comparisons found that only 20% of the predicted TM7 proteins had >60% homology to
previously sequenced proteins. That means most genes from TM7 are novel, with low
similarity to any other gene studied so far. Furthermore, a third (33.3%) of the predicted
TM7 proteins were less than 30% homologous to previously sequenced proteins (Marcy
et al., 2007). The most recent and most complete genome of TM7 from the human oral
cavity was obtained by utilizing the genomic data of TM7a as a scaffold for 454
pyrosequencing (Liu et al., 2012). This resulted in the identification of an additional 703
genes that were not recovered by Marcy et al. (2007); however, the genome is still
incomplete. The most recent and most complete genome from activated wastewater was
obtained by utilizing the Illumina HiSeq2000 sequencing platform (Albertsen et al.,
7

2013). The average TM7 genome size was determined to be 1 Mbp, which is close to the
lower limit of free-living bacteria (Albertsen et al., 2013).
Protein analysis from the identified genes provides insight to the metabolic and
physiological properties of TM7. Physiological properties include the H+ anti-porter,
involved in drug resistance, as well as cytochrome p450, which provides resistance to
toxic compounds (Marcy et al., 2007). Gene products for the type IV secretion system
were also present. The type IV system plays a role in the uptake of plasmids, potentially
providing the cell with antibiotic resistance (Marcy et al., 2007; Albertsen et al., 2013).
Type IV pili genes were discovered potentially providing the bacterium the means of
adherence to endothelial cells, as well as a means to contribute in biofilm formation.
Furthermore, Type IV pili are known to provide gliding motility in gram-positive bacteria,
further suggesting TM7’s gram-positive origin (Marcy et al., 2007; Albertsen et al. 2013).
Metabolic genes discovered include those involved in: ATP synthesis, glycolysis, the
tricarboxylic acid cycle, and salvage pathways (Marcy et al., 2007). However, the
completed genome of TM7 in activated wastewater suggests that TM7 can only use the
pentose phosphate and heterolactic fermentation pathways. (Albertsen et al. 2013)
Molecular Methods for the Detection and Quantification of TM7
TM7 bacteria account for approximately 0.3% of the total bacterial population in
the human oral cavity (Brinig et al., 2003). Therefore, it is important to perform an
efficient genomic DNA (gDNA) extraction to ensure the presence of such rare bacteria in
the extracted sample. Furthermore, the presence of contaminants must be limited due to
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known inhibitory properties during PCR amplification of the 16S rRNA gene. For
instance, contaminants in soil and wastewater such as humic acids inhibit polymerase
activity. In addition, humic acids are commonly found in DNA extractions as they have a
similar charge to DNA (Yeates et al., 2003). Therefore, following DNA extraction the
purity of DNA must be determined using a spectrophotometer to ensure the absence of
contaminants. Using a spectrophotometer, a 260/230 nm ratio above 2 indicates pure
DNA, while lower values suggest the possibility of contamination by compounds such as
humic acid. In addition, the 260/280 nm ratio can indicate the presence of protein
contamination in the DNA extraction. A 260/280 nm value of 1.8 is indicative of pure
DNA, however as the ratio increases so does the relative abundance of protein
contamination (Yeates et al., 2003).
The DNeasy blood and tissue kit (Qiagen, Valencia, CA) is commonly utilized to
perform genomic DNA extractions from various human anatomical sites. This kit has
been successfully utilized to obtain TM7 gDNA from the oral cavity (Dinis et al., 2011).
That same study used the suggested modified protocol included in the kit for grampositive bacterium as TM7 is thought to be gram-positive-like (Hugenholtz et al., 2001).
The gram-positive protocol makes use of chemical means to lyse the bacterial cells. The
principal component is lysozyme, which catalyzes the hydrolysis of N-acetylmuramic
acid and N-acetyl-D-glucosamine residues, abundant components of the peptidoglycan
cell wall of gram-positive bacteria (Mckenzie and White, 1991). The gDNA is then
isolated by ethanol precipitation (Yeates et al., 2003).
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PCR and Cloning
Once pure gDNA is obtained, the 16S rRNA gene is amplified using PCR, then
PCR amplicons are cloned into Escherichia coli cells. TM7 16S rRNA sequences were
originally obtained in 2001 in a study utilizing PCR with general bacteria primers BAC
8F and BAC 1492R (Hugenholtz et al., 2001). These general bacterial primers target a
large proportion of the bacterial community (DeLong, 1992) and TM7 sequences were
detected within that community. To target TM7 specifically, a TM7 primer was created
known as TM7 1177R (Brinig et al., 2003). In combination, the BAC 8F and TM7
1177R primer pair has been utilized to PCR amplify TM7 16S rRNA genes, of about
1,189 base pairs, in a variety of samples (Brinig et al., 2003; Dinis et al., 2011). PCR
reactions utilizing these primers was performed using Taq DNA polymerase and an
annealing temperature of 64°C (Brinig et al., 2003). The resulting PCR products were
cloned using the TOPO-TA cloning kit in combination with TOP10 chemically
competent E. coli cells (Invitrogen, Carlsbad, California). The clone library generated
was then screened for clones with the correct insert size (~1,189 bp) via PCR and
plasmids were extracted from each positive clone.
16S rRNA sequencing and Phylogenetic Analysis
BigDye sequencing methods (e.g. Sanger sequencing) have been widely used to
obtain 16S rRNA gene sequences (Applied Biosystems, Foster City, California). To
retrieve the entire sequence of the PCR amplicon cloned, vector-specific primers (M13F
and M13R) are used (Paster et al., 2001).
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The first step in DNA sequence analysis is to clean each raw DNA sequence file
of poor-quality nucleotide bases. The nucleotide quality is obtained from the
chromatograms generated during sequencing. The chromatogram is a representation of
the DNA sequence. It presents the relative signal strength of each DNA base (adenine,
cytosine, thiamine, and guanine), which determines the position of nucleotides within the
sequence (CodonCode Corporation, 2009). There are multiple programs to aid in the
cleaning process of DNA sequences. CodonCode Aligner (CodonCode Corporation,
Dedham, Massachusetts) is a program that will automatically remove portions of the
DNA sequence with weak or mixed signals. CodonCode Aligner can also remove vector
sequence, improving the overall quality of the insert.
Once sequences are cleaned they must be compared to a database to confirm their
TM7 identity. The National Center for Biotechnology Information (NCBI) contains the
GenBank database that houses non-redundant DNA sequences (Altschul et al., 1997)
which includes thousands of 16S rRNA genes. NCBI Basic Local Alignment Search
Tool (BLAST) can be utilized to compare users’ sequences to those housed in GenBank.
The BLAST tool allows users to determine the similarity or novelty of their sequences
(Altschul et al., 1997).
In order to conduct a phylogenetic analysis, the DNA sequences must be aligned
and compared. The Greengenes database only houses 16S rRNA gene sequences and
provides multiple tools for sequence preparation (DeSantis et al., 2006). The Near
Alignment Space Termination (NAST) tool is one such program that aligns 16S rDNA
sequences to a 7,682-character scaffold, allowing for a systematic approach for 16S
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rDNA comparisons (DeSantis Jr et al., 2006). This scaffold was created using 10,000
representative 16S rRNA genes from the Greengenes database. Furthermore, the
Greengene database provides chimera checking utilizing Bellerophon. A chimera is an
artifact of PCR, which contains multiple sequencing fragments from different organisms
in a single sequence (Cole et al., 2003). Bellerophon screens the user-imported
sequences for the presence of chimeras (Cole et al., 2003). Chimeric sequences are
subsequently discarded from the analysis.
Phylogenetic relationships of 16S rRNA genes are performed by software such as
ARB. ARB is an open source software that allows the comparison of 16S rRNA (Ludwig
et al., 2004). ARB compares both the primary and secondary structure of 16S rRNA
gene sequences to 236,469 reference sequences making it the most powerful software to
conduct rRNA comparisons. Phylogenetic trees can be constructed within the ARB
software by using a neighbor-joining algorithm. In this algorithm, each organism is
placed in an individual branch (Ludwig et al., 2004). A ‘node’ signifies the location
where the branches separate. Because Neighbor-joining trees assume a molecular clock,
each node signifies a common ancestor (Ludwig et al., 2004). The branch lengths depict
the organism divergence to its common ancestor, based on nucleotide mutations. The
longer the branch, the more divergent the two organisms are from one another (Ludwig et
al., 2004). Furthermore, the probability that each node occurred is signified by a
bootstrap value (Ludwig et al., 2004). Repeating the generation of the tree at least 100
times derives a bootstrap value, which is the percentage that the node occurred at a
particular location (Ludwig et al., 2004). Finally, to increase the bootstrap values, thus
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the accuracy of the tree, a distantly related sequence is added to root the tree (Ludwig et
al., 2004). This root allows all sequences to be compared to a single common ancestor.
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Quantitative PCR
Quantitative polymerase chain reaction (qPCR) utilizes fluorescently labeled
probes or dyes in order to determine the absolute quantity of a target nucleic acid
sequence (Applied Biosystems, 2005). Quantification of nucleic acid targets in real time
is possible in qPCR by fluorescence readings that are taken at the end of every PCR cycle.
There are two main methods in which fluorescence can be detected by the qPCR
thermalcycler; the first utilizes nucleic acid dyes, and the second uses fluorescently
labeled probes (Applied Biosystems, 2005).
In the first method, a fluorescently labeled dye such as SYBR green is responsible
for the fluorescence of target nucleic acids. SYBR green is a general nucleic acid stain
that binds to double-stranded DNA (dsDNA) but not single-stranded DNA (ssDNA)
(Applied Biosystems, 2005). Due to this feature, SYBR green will bind only to newly
synthesized dsDNA amplicons at the end of each PCR cycle but will not bind and
fluoresce ssDNA such as primers or probes. According to Applied Biosystems, this
method is preferred for determining the abundance of a sample with a known DNA
composition such as a purified plasmid; however, it is not suitable for samples that
contain a variety of unknown sequences, such as those obtained from genomic DNA
extractions from environmental or human-associated mixed microbial communities. This
is because SYBR green is a non-specific dye, binding to any double-stranded nucleic acid,
including non-specific PCR products, thus overestimating the targets’ true abundance.
In the second and more precise method, a TaqMan Probe assay is utilized. A
TaqMan probe is an oligonucleotide probe that is complementary to the target DNA
14

strand and is used for inducing fluorescence to the target amplicon (Applied Biosystems,
2005). The TaqMan probe is tethered to a fluorescent reporter on its 5’ end and a
quencher on the 3’ end. When excited by a light source of correct wavelength, the
fluorescent reporter emits energy in the form of light (fluorescence) that can be detected
by the qPCR machine (Applied Biosystems, 2005). However, the Applied Biosystems
manual states that while the quencher remains attached to the probe, the quencher absorbs
the emitted light from the reporter, fluorescence is not produced, preventing the detection
of the probe. In order for the reporter to be detected, it must be cleaved from the probe.
In addition to the fluorescent probe, TaqMan uses two primers that, like PCR, flank the
piece of DNA to be amplified. The TaqMan probe is designed to bind to a DNA target
sequence between the two primers. During qPCR, all intact probes do not fluoresce due
to the presence of the quencher, however, as Taq Polymerase elongates a target amplicon,
the polymerase will reach the probe bound to DNA and will cleave the reporter from the
attached probe, the fluorescence from the reporter is no longer quenched, allowing for its
detection (Applied Biosystems, 2005). As the qPCR cycles progress, more probes are
cleaved and more fluorescence signal is produced. Hence, qPCR is a quantitative method
because the amount of fluorescence detected is linked to the amount of a particular target
DNA in a sample. As with FISH probes, TaqMan probes can be designed to target a
variety of sample sizes. Broad range probes such as BAC 338 have been designed to
target most prokaryotes (Murray et al., 1998), and specific probes such as TM7a 1033
have been designed to target a specific clade of TM7, TM7a (Dinis et al., 2011). In order
to prevent possible fluctuations between qPCR reactions caused by pipetting or
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concentration errors, the ABI mastermix provides a passive reference dye. The passive
reference dye is utilized to normalize reporter detection fluctuations between qPCR
reactions (Applied Biosystems, 2005).
Utilizing qPCR to detect the abundance of TM7 has been performed previously
(Brinig et al., 2003; Dinis et al., 2011). Brinig et al. (2003), developed a protocol for the
quantification of total bacteria and TM7 specific populations in Human subgingival
crevice samples. In this study, broad range 16S primers, BAC 8F and BAC 515R (Lane
et al., 1985), were used in conjunction with TaqMan probe BAC 338 (Murray et al.,
1998) for total bacterial quantification. TM7 quantities were determined by utilizing
TM7 specific primers, TM7 910F and TM7 1177R in conjunction with TaqMan probe
TM7 1093 (Brinig et al., 2003). Thermocycling conditions in this study were preformed
according to Applied Biosystems protocols with a modification to the annealing
temperatures. The total bacteria quantification reaction utilized three separate annealing
temperatures: 55°C, 60°C, and 65°C (Brinig et al., 2003). The TM7 quantification
reactions used a single annealing temperature of 61°C (Brinig et al., 2003). In order to
define the quantification of bacteria within the samples, a standard curve was generated
utilizing a plasmid with a known copy number and was serially diluted. The plasmid
utilized for the generation of the standard curve encompassed a TM7 sequence that
contained complimentary targets to all primers and probes utilized in the study (Brinig et
al., 2003).
Once rRNA gene copy numbers are obtained by the qPCR reaction, they must be
converted to cells per gram. Factored in that conversion is the fact that some prokaryotic
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genomes contain more than one copy of the same 16S rRNA gene, some containing up to
15 16S rRNA gene copies per cell (Acinas et al., 2004). Based on analyses of complete
bacterial genomes, it was determined that the average bacterium contains 3.5 16S rRNA
genes per cell (Acinas et al., 2004). Based on the two published TM7 genomes, TM7
appear to have two 16S rRNA gene copies per cell (Marcy et al., 2007; Podar et al.,
2007). Therefore, a 3.5 16S rRNA gene copy number per cell was used when quantifying
bacteria, and two copy numbers was be used when quantifying TM7.
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Materials and Methods

Patient Selection
Six healthy individuals were selected randomly to participate in this study. The
patients were chosen based on their availability to be sampled by the dentist. In
compliance with the Institutional Review Board (IRB) #F0904009, each patient was
asked to sign a consent form and then asked to fill out an overall health survey (Table 2).
Once the surveys were collected, each individual was given a randomly generated ID
number to protect patient identity.
Sample Collection and Processing
A local licensed dentist first determined the health condition of each patient’s
tooth based on quantitative (measurements of pocket depths, Figure 1) and qualitative
(general observations of oral tissue health) observations. Then, the same dentist used
sterile techniques to collect all oral plaque samples with dental picks (Figure 1). Five to
six individual teeth were sampled from each patient. The subgingival plaque sample
from each tooth was notarized based on the tooth’s position, anatomical location, and
sampling surface (facial or lingual) (Figure 2). Each individual tooth’s collected oral
plaque was put into individual 1.5 mL sterile eppendorf tubes (Eppendorf, Hauppauge,
NY). Each tube contained 200 μl sterile 1x PBS solution, was pre-weighed in a Mettler
Toledo AB54-S balance (Mettler Toledo, Columbus, OH), and labeled with the patients
ID followed by the tube number (1 - 6). Hence, each tube had a unique number linked
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to the patient and the exact tooth from which the plaque was collected.

Figure 1. Use of probe to measure periodontal pocket depth (nidcr.nig.gov, 2013). The
depth of each periodontal pocket was measured as shown to determine the health status of
each tooth.
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Figure 2. Universal tooth numbering chart (DentalImplants-USA, 2013). Each number
represents a unique tooth. Teeth are categorized based on their anatomical position,
posterior (#1-5, 12 - 21, 28 - 32) or anterior (#6 – 11, 22 – 27), and sampling surface,
facial (side of tooth facing the cheek) or lingual (side of tooth facing the tongue).
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Samples were transferred to the laboratory on ice, and processed within 1 h of
sampling. Each tube was weighed again in a Mettler Toledo AB54-S balance (Mettler
Toledo, Columbus, OH) to determine the net weight of collected oral plaque per sample.
After each sample’s weight was determined, DNA was immediately extracted.
DNA Extraction
Bacterial genomic DNA was extracted from each sample using a Qiagen DNeasy
Blood and Tissue Kit (Qiagen, Valencia, California). DNA was extracted according to
the manufacturer’s gram-positive bacteria protocol (protocol revision 07/2006).
Following DNA extraction, concentration and purity of DNA was determined using a
Nanodrop ND-1000 spectrophotometer (Thermo Scientific, Waltham, MA) with version
3.7 software (Thermo Scientific, Waltham, MA). All extracted nucleic acid was stored at
-20°C.
Bacteria 16S rRNA Gene Amplification
To determine if the bacterial genomic DNA was successfully extracted, PCR was
run to screen each sample for the presence of the 16S rRNA gene. Broad-range primers
BAC 8F and 515R were used to amplify the 16S rRNA target (Table 1). PCR
amplification was performed using a 1/10 dilution of each extracted sample. Each
individual 25 µl PCR reaction contained the following reagents: 2.5x10-2 units of GOTaq
Flexi DNA polymerase (Promega, Madison, Wisconsin), 1x GOTaq Reaction Buffer
(Promega, Madison, Wisconsin), 2.0 mM MgCl2, 0.2 mM of each deoxyribonucleotide,
0.2 μM of each forward and reverse primer, and 5 to 50 ng of nucleic acid. The PCR
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reactions were carried out using an Applied Biosystemes 2720 Thermal Cycler (Applied
Biosystems, Foster City, California) with the following cycling conditions: initial
denaturation step of 95°C for 2 min then 35 cycles of 95°C for 30 sec, 55°C for 30 sec,
and 72°C for 1.5 min, followed by a final elongation step of 72°C for 5 min.

22

Table 1. Primers and Probes

General
Bacteria

General
TM7
TM7a
Specific

BAC 8F
BAC 515R
BAC 338I
BAC 338II
BAC 338III
TM7 910F
TM7 1177R
TM7 1093
TM7a 997F
TM7 1177R
TM7a 1033

PCR Primer
PCR Primer
qPCR Probe
qPCR Probe
qPCR Probe
PCR Primer
PCR Primer
qPCR Probe
PCR Primer
PCR Primer
qPCR Probe

AGA GTT TGA TCM TGG CTC AG
KAC CGC GGC KGC TGG CA
GCT GCC TCC CGT AGG AGT
GCA GCC ACC CGT AGG TGT
GCT GCC ACC CGT AGG TGT
CAT AAA GGA ATT GAC GGG GAC
GAC CTG ACA TCA TCC CCT CCT TCC
AGT CCA TCA ACG AGC GCA ACC
TCC CGA GAA GAT TTA CG
GAC CTG ACA TCA TCC CCT CCT TCC
ATC TGT CAC CGA GTT CCA

Following PCR amplification, amplicons were run on a 1.5% agarose gel
(International Biotechnologies Inc., New Haven, Connecticut) containing 0.025%
Ethidium Bromide. Gels were casted on a Horizon 58 gel electrophoresis system
(Invitrogen, Carlsbad, California) with a FB300 electrophoresis power supply (Fisher
Scientific, Waltham, Massachusetts), running at 90 V and 400 mA for 30 min. Following
electrophoresis, gel visualization and imaging was performed on a Bio-Rad Universal
Hood II system (Bio-Rad, Hercules, California), and annotated using Quantity One
Version 4.6 Software (Bio-Rad, Hercules, California).
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Quantitative PCR
Quantitative PCR (qPCR) was performed on all samples that tested positive for
the presence of 16S rDNA using PCR as described above. A TaqMan probe-based
absolute quantification assay was performed on an Applied Biosystems 7300 Real Time
PCR System (Applied Biosystems, Foster City, California). For each oral sample, three
subgroups of prokaryotes were quantified using qPCR: total bacteria, total TM7, and total
TM7a. Each experiment was run three times to generate an average, and each oral
sample was run in triplicate per experiment, for a total of nine data points per oral sample.
As part of the absolute quantification assay a standard curve was generated for each run
to determine the amount of 16S rDNA in the samples.
In order to generate a standard curve, a positive control plasmid was utilized that
contained complimentary targets for all qPCR primers and probes used in this study. The
concentration of the positive control plasmid was determined using a Nanodrop ND-1000
spectrophotometer (Thermo Scientific, Waltham, MA) and diluted to a final
concentration of 5.6 ng/ul, which correlates to be 1x109 molecules of plasmid per ul. For
the generation of each standard curve the positive control plasmid was serially diluted
from 1x108 to 1 plasmid copy number(s) per ul, hence each standard curve had eight data
points. As with oral samples, each plasmid dilution was run in triplicate for each of the
three experimental runs.
Experimental setup including annotating the standard curve controls and oral
samples was performed with the 7300 System SDS software version 1.4 (Applied
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Biosystems, Foster City, California) using the absolute quantification platform.
Experimental parameters and cycling conditions were as follows for each of the three
phylogenetic groups targeted:
Bacterial quantification. Each qPCR reaction contained a final volume of 20 μl
composed of 10 μl TaqMan Universal PCR Master Mix, No AmpErase UNG (Applied
Biosystems, Foster City, California), 1.8 μM of the forward primer BAC 8F, 3.6 μM of
the reverse primer BAC 515R, and contained 0.1 μM of each of the following TaqMan
probes: BAC 338I, BAC 338II, and BAC 338III (Table 1). The TaqMan probes
contained a FAM fluorescent reporter and a black hole quencher. Cycling parameters
were defined as follows: initial denaturation and Taq activation step of 95°C for 10 min,
then 45 cycles of 95°C for 30 sec, 55°C for 30 sec, 60°C for 45 sec, 65°C for 15 sec, and
72°C for 30 sec as previously published (Brinig et al. 2003). At the end of each 72°C
elongation step, fluorescent levels were read and recorded automatically by the qPCR
machine.

TM7 quantification. Each qPCR reaction contained a final volume of 20 μl
composed of 10 μl TaqMan Universal PCR Master Mix, No AmpErase UNG (Applied
Biosystems, Foster City, California), 0.9 μM of the forward primer TM7 910F, 0.9 μM of
the reverse primer TM7 1177R, and 0.1 μM of TaqMan probe TM7 1093 containing a
FAM fluorescent reporter and black hole quencher (Table 1). Cycling parameters were
defined as follows: initial denaturation and Taq activation step of 95°C for 10 min, then
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45 cycles of 95°C for 30 sec, 61°C for 30 sec, and 72°C for 30 sec. At the end of each
72°C elongation step, fluorescent levels were read and recorded.
TM7a quantification. Each qPCR reaction had a final volume of 20 μl composed of 10
μl TaqMan Universal PCR Master Mix, No AmpErase UNG (Applied Biosystems, Foster
City, California), 0.9 μM of the forward primer TM7a 997F, 0.9 μM of the reverse primer
TM7 1177R, and 0.1 μM of TaqMan probe TM7a 1033 containing a FAM fluorescent
reporter and black hole quencher (Table 1). Cycling parameters were defined as follows:
initial denaturation and Taq activation step of 95°C for 10 min, then 45 cycles of 95°C
for 30 sec, 61°C for 30 sec, and 72°C for 30 sec. At the end of each 72°C elongation step,
fluorescent levels were read and recorded.
qPCR Raw Data Conversions

Following each run, the quantification of targeted 16S rRNA genes was obtained,
commonly referred to as gene copy number. Because each sample starting material
(plaque) was of different weight, measurements were normalized by the original plaque
weight in order to compare the quantification of 16S rRNA gene copy number among the
various samples. In addition the number of 16S rRNA genes in a bacterial genome varies
depending on the phylogenetic group. Therefore, an equation was used to convert total
16S rRNA genes to cells/g of pelleted oral plaque (Figure 3). The following conversion
was performed to obtain cells/g of pelleted oral plaque from the raw qPCR data: 1)
Corrections for gene copy number per cell, using an estimated 3.5 average rRNA gene
copy number per cell for total bacteria quantification (Klappenbach et al., 2001) and 2.0
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average rRNA gene copy number per cell for total TM7 and TM7a (Marcy et al., 2007;
Podar et al., 2007), 2) corrections for DNA sample dilution used for qPCR reactions, and
3) corrections for DNA concentration due to DNA extraction methods.

Figure 3. Calculation for converting raw qPCR data, rRNA gene copy number/μl, to
cells/g of pelleted oral plaque. Conversions included corrections for gene copy number
per cell, sample dilution used, and changes in volume during DNA extraction.
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Results
Patient Selection
Four males and two females participated in this study (Table 2). The average patient was
in their mid twenties. Two patients were current or previous smokers. All patients
brushed their teeth twice daily; however, the frequency of dental flossing ranged from 1 –
7 times per week. Two patients experienced bleeding upon flossing. Three patients bit
their fingernails, and no patients had extensive crown or bridge work.
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Table 2. Summary of patient health surveys. All reports were collected the day of plaque
collection
Patient ID
DXD

ETP

FYZ

GMO

KPM

JNW

Gender

F

M

M

M

M

F

Age

26 - 30

31 +

21 - 25

21 - 25

26 - 30

21 - 25

Height

5'3'

5'10"

6'0"

5'10"

6'0"

5'4"

Weight

-

178

170

130

165

104

Health
condition

No

No

No

No

No

No

Smoker

Yes

No

No

No

Yes

No

Allergies

Yes

No

No

No

Yes

No

Brush
Frequency

2x

2x

2x

2x

2x

2x

Floss

7x

6x

5x

1x

7x

5x

Bleeding Gums

Yes

No

Yes

No

No

Yes

Finger Biting

No

No

Yes

No

Yes

Yes

Extensive
Crown or
Bridge Work

No

No

No

No

No

No
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Sample Collection and Processing
Between five and six oral plaque samples were collected from each of the six
patients for a total of 34 samples (Table 3). An average of 0.0028 g of dental plaque was
collected from each sample with a range from 0.0013 g to 0.0048 g (Table 3). Among
the 34 samples, 23 were from males and 11 from females. The sites from which samples
were collected included 19 from the facial side and 15 from lingual, whereas 23 samples
were from posterior sites and 11 from anterior sites (Table 3). Pocket depth (PD) was
used as a preliminary measure of the gingival health status. PD ≤ 3 mm are considered
healthy, whereas PD ≥ 4 are considered unhealthy (or diseased). The average PD among
all sampled sites was 2.7 mm with a range from 2 mm to 5 mm. Thirty sites were
classified as healthy (PD ≤ 3 mm) and four sites exhibited gingivitis (PD ≥ 4) (Table 3).
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Table 3. Subgingival Plaque Weights. Each tube used to collect the samples was labeled and filled with 200 μl sterile H2O and
weighed to obtain the initial tubes weight. Following sample collection, each tube was weighed a second time to determine the
weight of the subgingival plaque. Pocket depth was determined by the dentist prior to collecting the sample.
Patient
DXD
Sample
Tooth
Tube
(g)

1
2F

2
6F

3
13L

ETP

4
19L

5
24F

6
31F

1
2F

2
5F

3
8L

4
30L

5
27F

6
13F

1.0070 1.0033 1.0129 1.0040 1.0021 1.0052 1.0036 1.0079 1.0071 1.0077 1.0035 1.0044

Tube
w/sample 1.0091 1.0068 1.0158 1.0061 1.0043 1.0075 1.0057 1.0099 1.0094 1.0099 1.0058 1.0077
(g)
Sample
(g)
Pocket
Depth
(mm)

0.0021 0.0035 0.0029 0.0021 0.0022 0.0023 0.0021 0.0020 0.0023 0.0022 0.0023 0.0033
3

3

3

2

3

2

31

2

5

3

3

2

3

Table 3. Subgingival Plaque Weights, continued.
Patient
FYZ
Sample
Tooth

1
2F

2
7L

3
13F

GMO
4
31F

5
25F

6
20L

1
2F

2
8F

3
15L

4
20L

5
26F

6
31F

Tube (g)

1.0129 0.9895 1.0026 1.0075 1.0051 1.0004 1.0126 1.0212 1.0064 1.0082 1.0039 1.0043

Tube
w/sample
(g)

1.0161 0.9918 1.0052 1.0107 1.0084 1.0034 1.0153 1.0244 1.0107 1.0107 1.0087 1.0076

Sample
(g)
Pocket
Depth
(mm)

0.0032 0.0023 0.0026 0.0032 0.0033 0.0030 0.0027 0.0032 0.0043 0.0025 0.0048 0.0033
3

2

4

4

2

4

32

2

3

2

3

3

2

Table 3. Subgingival Plaque Weights continued.

Patient
JNW

KPM

1

2

3

4

5

1

2

3

4

5

Tooth

4L

10L

20L

24F

30L

2F

20L

18L

31L

11F

Tube
(g)

1.0006 0.9890 1.0057 1.0039 1.0033 1.0062 1.0046 1.0044 1.0038 1.0122

Sample

Tube
w/sample 1.0043 0.9918 1.0081 1.0071 1.0069 1.0095 1.0081 1.0066 1.0051 1.0136
(g)
Sample
(g)
Pocket
Depth
(mm)

0.0037 0.0028 0.0024 0.0032 0.0036 0.0033 0.0035 0.0022 0.0013 0.0014

3

2

3

3

3
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3

2

3

2

2

DNA Extraction
Genomic DNA extracted yielded an average of 14.27 ng/μl with a range of 1.62
ng/μl - 51.34 ng/μl (Table 4). DNA purity was determined by the A260/A280 ratio,
which averaged 1.90±0.30, indicating that the extracted DNA contained predominantly
DNA (Table 4).

34

Table 4. Genomic DNA Extraction. Extractions were performed using the Qiagen DNeasy Blood and Tissue Kit. DNA
concentration expressed in ng/μl using a NanoDrop spectrophotometer. DNA purity is expressed as the A260/A280 ratio.
Tooth # followed the standard numbering of teeth used in dentistry. F = facial and L = lingual side of the tooth.
Patient
ETP

DXD
Sample
Tooth
ng/μl
A260/A280
Ratio

JNW

1
2
3
4
5
6
1
2
3
4
5
6
1
2
3
4
5
2F
6F
13L
19L 24F 31F
2F
5F
8L 30L 27F 13F
4L 10L 20L 24F 30L
24.94 19.46 12.22 26.86 9.67 18.63 1.62 6.05 9.65 9.03 3.07 12.63 6.69 7.26 13.65 4.46 13.54
1.93

1.95

1.92

1.92

1.81

2.03

1.71

1.69

2.57

1.81

2.14

1.86

2.14

1.5

1.5

2.16

1.82

Table 4. Genomic DNA Extraction Continued.
Patient
FYZ
Sample
Tooth
ng/μl
A260/A280
Ratio

GMO

KPM

1
2
3
4
5
6
1
2
3
4
5
6
2F
7L
13F 31F 25F
20L
2F
8F
15L
20L
26F
31F
20.37 9.38 20.22 9.07 15.57 26.95 19.67 20.56 16.62 13.36 51.34 28.68

1
2F
6.8

2
3
4
5
20L 18L 31L 11F
10.49 4.98 4.08 7.65

1.81

2.97

1.65

1.43

1.74

1.67

1.93

1.72

1.89

1.95
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2.02

1.85

2.09

1.95

1.8

1.38

2.12

Bacteria 16S rRNA Gene Amplification
Initial PCR screening showed that all 34 oral samples contained the 16S rRNA
gene from bacteria as determined from amplifying samples with general bacteria 16S
rRNA primers, BAC 8F and BAC 515R. All samples were compared to a positive
control plasmid in a 1.5% agarose gel. A 1/10 dilution of all DNA samples was used to
conserve DNA (Figure 4).

Figure 4. PCR screening results from extracted genomic DNA using BAC 8F and BAC
515R. A 1/10 dilution of each genomic DNA sample was used. PCR products were run
on a 1.5% agarose gel with a low range ladder and positive control plasmid as a reference.
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Quantitative PCR
Real time quantitative PCR was used to quantify the 16S rRNA gene in each oral
plaque sample. Three separate qPCR assays were performed to quantify the i) total
bacteria, ii) TM7, and iii) TM7a populations. qPCR quantification was based on a
standard curve generated using a positive control plasmid serially diluted from 108 to 1
gene copy number per μl. At the end of each run, the ABI 7300 qPCR software produced
a best-fit line using five sequential dilution points of the standard curve (Table 5). From
the slope of the best-fit line the coefficient of correlation (R2) was calculated. The ideal
qPCR run (100% efficiency) has a slope of -3.33 and an R2 of 100%, indicating each 16S
rDNA gene in the sample was copied (doubled) every qPCR cycle. For all three qPCR
target groups in the oral samples (Bacteria TM7 and TM7a) the R2 values were greater
than 99% (Table 5), signifying high accuracy of results. The normalized data collected
over three runs produced amplification efficiencies near the ideal value of one (Table 5).
Among the six patients, all were positive for the presence of bacteria as expected. TM7
was detected in all patients and in 32 of 34 (94.1%) samples. TM7a was detected in 5 of
6 (83%) patients and in 22 of 34 (64.7%) samples.
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Table 5. Amplification efficiency values from qPCR experiments. Each assay consisted
of three runs in triplicates per sample, total sample population (n = 9). Numbers in
parenthesis are ± standard error of the mean.

qPCR Assay
Target

Amplification
Efficiency

Slope

R2

Standard
Range

Bacteria

0.96 (0.013)

3.42 (0.035)

>99%

104 - 108

TM7

0.95 (0.022)

3.46 (0.036)

>99%

103 - 107

TM7a

0.99 (0.0024)

3.37 (0.0059) >99%

102 - 106

While the concentration of bacteria was more consistent (small standard
deviation), the concentrations of TM7 and TM7a in oral plaque were more dynamic from
patient to patient (Table 6 and Figure 5). Bacteria concentration ranged from 4.84x1010
cells g-1 (Patient DXD) to 5.08x109 cells g-1 (Patient KPM) with an overall average of
2.26x1010 ± 9.24x109 (mean ± s.e.m.; n = 6) cells g-1 (Figure 5). TM7 counts ranged
from 3.36x108 cells g-1 (Patient FYZ) to 1.08x107 cells g-1 (Patient ETP) with an overall
average of 1.78x108 ± 9.21x106 (n = 6) cells g-1 (Figure 5). TM7a counts ranged from
1.39x108 (Patient DXD) to 5.10x104 (Patient JNW) with an overall average of 3.36x107 ±
2.53x106 (n = 6) cells g-1 (Figure 5).

38

Figure 5. Average number of total bacteria, TM7, and TM7a, in human oral subgingival
plaque. Values represent the mean of all sampled teeth within the patient.
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To understand if the concentrations of bacteria influence the total TM7 or TM7a
populations, the relative abundance of TM7 and TM7a was calculated. In other words,
the concentrations of TM7 and TM7a were normalized to the total Bacteria concentration.
In addition, TM7a was normalized to the total TM7 concentration. The average relative
abundance of TM7 (average TM7/average bacteria) was 1.06% ± 0.025% (n = 32) with a
range of 3.29% ± 1.58% (Patient JNW; n = 5) to 0.16% ± 0.10% (Patient ETP; n = 6)
(Table 6). The average relative abundance of TM7a to bacteria (average TM7a/average
bacteria) was 7.59x10-2% ± 3.08x10-2% (n = 22) and to TM7 (average TM7a/average
TM7) 18.19% ± 6.68% (Table 6). The range of TM7a to bacteria was 2.88x10-1% ±
2.16x10-1% (Patient DXD; n = 6) to 1.00X10-3% ± 8.65X10-4% (Patient JNW; n = 5),
and to TM7 was 65.27% ± 51.58% (Patient DXD; n = 6) to 3.05x10-2% ± 2.69x10-2%
(Patient JNW; n = 5) (Table 6).
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Table 6. Quantification and relative abundance of TM7a based on qPCR assay.
Percentage of TM7a from bacteria calculated as average TM7a (cells g-1 )/average
bacteria (cells g-1 ). Percentage of TM7a of TM7 calculated as average TM7a
(cells g-1 )/average TM7 (cells g-1 ).

Patient ID
DXD

ETP

FYZ

GMO

JNW

KPM

TM7a
Cells/g
Human
Oral
Plaque
(±S.E.M.)

1.39x108
(2.74x107)

3.12x106
(1.32x106)

1.23x107
(2.33x106)

2.84x107
(6.77x106)

5.10x104
(2.68x104)

0

Percent
TM7a of
Total
Bacteria
Population
(±S.E.M.)

2.88x10-1%
(2.16x10-1%)

4.61x10-2%
(4.90x10-2%)

5.20x10-2%
(2.86x10-2%)

6.83x10-2%
(6.02x10-2%)

1.00x10-3%
(8.65x10-4%)

0%

Percent
TM7a of
Total TM7
Population
(±S.E.M.)

65.27%
(51.58%)

28.92%
(20.64%)

3.67%
(2.12%)

8.81%
(2.42%)

3.05x10-2%
(2.69x10-2%)

0%
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TM7 bacteria were present in all patients and in 32 of 34 (94.1%) samples,
suggesting TM7 is ubiquitous in the human oral cavity; however, a larger sample size
would be needed to confirm such finding. TM7a populations on the one hand, were not
prevalent in all samples or patients, and the abundance of total bacteria or total TM7 did
not influence the abundance of TM7a. There was, however, a statistically significant
difference in mean TM7a abundance between (p < 0.0005, t = 4.256, n = 34) facial sites
(5.15x107 ± 9.49x106; n = 19) and lingual sites (9.78x106 ± 2.01x106; n = 15) (Figure 6).
TM7a was ~5.3 times more abundant in sites facing the human cheeks than sites facing
the tongue. TM7a was also significantly more abundant (p < 0.05, t = 2.162, n = 34) in
posterior sites (3.95x107 ± 7.90x106; n = 23) than in anterior sites (2.00x107 ± 4.36x106; n
= 11) (Figure 7). TM7a was ~2 times more abundant in the front of the mouth as
compared to the back. There was no observed statistical significance regarding the
abundance of TM7a between healthy (3.70x107 ± 6.39x106; n = 30) and gingival sites
(8.12x106 ± 2.72x106; n = 4) (Figure 8), even though TM7a was found to be ~4.5 times
more abundant in healthy sites. Suggesting that there are other unidentified factors
influencing the abundance and prevalence of TM7a in subgingival plaque.
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*

* p < 0.0005

Figure 6. Average number (cells g-1 ) of TM7a cells from facial and lingual plaque
samples.
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*

* p < 0.05

Figure 7. Average number of TM7a cells (cells g-1 ) from anterior or posterior plaque
samples.
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Figure 8. Average number of TM7a cells (cells g-1 ) from Healthy or Gingival plaque
samples. Health status determined by depth of periodontal pocket, classified as either
healthy (PD ≤ 3) or gingival (PD ≥ 4).
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Discussion
Assay to Target TM7a in Human Subgingival Plaque
TM7a has been detected in both environmental and human sites. However, it has
only been quantified in activated wastewater and not in human samples. In this study, the
first quantification of TM7a in human oral plaque samples was performed. The
environmental TM7a from wastewater has been named “TM7a-like” by its founders
(Dinis et al. 2011). The qPCR TaqMan assay to Target TM7a-like in activated
wastewater used two primers (TM7a 997F and TM7a-like 1112R) plus one fluorescent
probe (TM7a 1033). In this study the same forward primer (TM7a 997F) and probe
(TM7a 1033) as in Dinis et al. (2011) was used, but also a broad range TM7 reverse
primer (TM7 1177R), which targets both TM7a and “TM7a-like” bacteria. In addition,
the qPCR assay used in this study, detects 25 TM7a phylotypes as compared to 20 TM7
phylotypes detected with the reverse primer used in the Dinis et al. (2011) qPCR assay.
This 25% increase in detection power to the qPCR assay can be significant if the
proportion of the 5 newly detected TM7 phylotypes are predominant members in a
particular sample site.
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Quantification of TM7 and TM7a in Human Subgingival Plaque
TM7 bacteria were present in all patients and in 32 of 34 (94.1%) samples. This
is consistent with a previous study surveying TM7 in human subgingival plaque, which
detected TM7 in 86 of 90 (96%) samples (Brinig et al. 2003). Results suggest the
division TM7 is common in the human oral cavity and perhaps even a permanent resident.
TM7a on the other hand, was detected in 5 of 6 (83%) patients and in 22 of 34 (64.7%)
samples. The only previous quantification of TM7a was performed in activated
wastewater (Dinis et al. 2011), which found “TM7a-like” in 4 of 23 (17.4%) samples,
suggesting that the factors that contribute to the prevalence of TM7a may differ from
other TM7 bacteria.
The relative abundance of TM7 (average TM7/ average bacteria) from human
subgingival plaque in this study was 1.06% ± 0.025% (SE), as compared to the previous
study by Brinig et al. (2003), which found TM7 to make up 0.3% of the total bacteria
community by real-time PCR. Although the relative abundance of TM7 in this study is
253% greater than found by Brinig et al. (2003), it is important to note the percentage of
TM7 in the previous study was calculated based on the total rRNA copy number/μl,
which did not take into account the normalization of average rRNA gene copy found in
the TM7 and bacteria genomes (see figure 3) as performed in this study, and is therefore
likely underestimated. The TM7 gene copy number was not available until 2007 (Marcy
et al. 2007), three years after the first TM7 qPCR quantification by Brinig et al. (2003)
was published.
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The relative abundance of TM7a to bacteria (average TM7a/average bacteria) in
this study was 7.59x10-2% ± 3.08x10-2% and to TM7 (average TM7a/average TM7)
18.19% ± 6.68%. TM7a has not been quantified in human oral samples, but based on the
previous quantification of TM7a in activated wastewater (Dinis et al. 2011), “TM7a-like”
was found to make up 0.01% of total bacteria and 0.44% of TM7. Although this is a pilot
study, these limited data suggests that TM7a is present in greater percentage in
subgingival plaque than in activated wastewater.
Consistent with other studies, there was no correlation between the abundance of
TM7 and gender, smoking status, or age (Brinig et al. 2003). TM7a on the one hand was
found to be significantly more abundant in posterior than anterior sites, as well as
significantly more abundant in facial than lingual sites. It is unknown as to what the
contributing factors are that favor TM7a preference for these locations; however, an indepth look at the total bacterial composition at these sites may shed some light on the
matter. TM7a was also found to be more abundant in healthy samples; however, this
finding was not statistically significant and is consistent with the previous study (Brinig
et al. 2003) that found TM7 to be more abundant in gingival sites, but not statistically
significant. Both this study and the one performed by Brinig et al. (2003) had relatively
small populations of gingival samples, 4 of 34 (11.8%) and 5 of 76 (6.6%), respectively.
Perhaps with a larger sample size, the significance of TM7 and TM7a at these sites can
be elucidated.
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Future Directions
The overall abundance of TM7 and TM7a were dynamic in human subgingival
plaque. Although the presence of TM7 was more consistent, the same could not be said
about TM7a. There are many factors, which can contribute to their prevalence including
diet, health, and the bacterial composition at each site. A future cross-sectional study
quantifying TM7a in a more diverse population could provide more details on TM7a
prevalence. Next-generation sequencing can identify the bacterial population from each
sample and may reveal trends that favor the prevalence of TM7 and TM7a in human
subgingival plaque.
In addition, a temporal study utilizing both a quantitative analysis and nextgeneration sequencing can provide a glimpse of how the bacterial population changes,
and how these changes reflect on the abundance and overall prevalence of TM7 and
TM7a at each site.

Conclusions
In this pilot study, TM7a was successfully detected and quantified in human
subgingival plaque. Consistent with previous studies, TM7 was not found to be
significantly more abundant in gingival samples as compared to healthy samples. TM7a
on the other hand was found to be significantly more abundant in facial sites as well as
posterior sites as compared to lingual sites and anterior sites respectively. A larger and
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more diverse sample size, including a wider array of diseased samples is needed to make
correlations between TM7a and human oral disease. Here we presented an optimized
assay that successfully quantified TM7a in human oral sites.
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